DeutschNewstral
Article
bizjournals.com on 2016-05-18 22:54
Seattle's first IPO since 2014: Biotech PhaseRx goes public on Nasdaq
Related news
- Venture-backed Md. biotech files for IPObizjournals.com
- Gaithersburg biotech firm files for IPObizjournals.com
Seattle biotech firm Silverback Therapeutics aims for $100M IPOSeattle Times- MMoleculin Biotech shares remain halted on Nasdaqmarketwatch.com
Vancouver biotech firm Absci files for IPOoregonlive.com
Seattle biotech Silverback Therapeutics prices upsized IPOseattletimes.com- Adaptive Biotech seeks $230 million in IPOSeattle Times
- Biotech developer trains sights on Seattle's homelessness crisisbizjournals.com
Bitcoin Miner Stronghold Launches Nasdaq IPObitcoinmagazine.com
Seattle's Real Change newspaper goes digitalKOMO News
The Biotech IPO Boom Will Continue, Nasdaq Execs PredictForbes- Mass. biotech IPO stampede continues as two more hit Nasdaqbizjournals.com
- Absci’s IPO values Vancouver biotech startup at $2 billionoregonlive.com
NYSE Cuts Fees to Court Biotech Listings Away From Nasdaqwsj.com
Smaller crowd for Seattle's 1st major event since outbreakFox News- TSeattle's New Minimum Wage Law Goes Into Effect Todaythestranger.com
Newton biotech goes public next weekBoston Herald- Berkeley cancer therapy startup Aduro Biotech seeks $86M in IPObizjournals.com
- Venture-backed Rockville biotech firm files for IPObizjournals.com
- San Francisco biotech CytomX files for $100 million IPObizjournals.com